awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35794472-32CCBE14-3F7A-4C61-96E7-29ACC842EA77
Q35794472-32CCBE14-3F7A-4C61-96E7-29ACC842EA77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35794472-32CCBE14-3F7A-4C61-96E7-29ACC842EA77
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.
P2860
Q35794472-32CCBE14-3F7A-4C61-96E7-29ACC842EA77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35794472-32CCBE14-3F7A-4C61-96E7-29ACC842EA77
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c437f96564d3c2a6a3dc01bcd4a1d5460e6bcd7
P2860
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.